Heightened resistance to host type 1 interferons characterizes HIV-1 at transmission and after antiretroviral therapy interruption. (2021)

First Author: Gondim MVP
Attributed to:  Design of HIV vaccines that stimulate T cell and NK cell immunity funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1126/scitranslmed.abd8179

PubMed Identifier: 33441429

Publication URI: http://europepmc.org/abstract/MED/33441429

Type: Journal Article/Review

Volume: 13

Parent Publication: Science translational medicine

Issue: 576

ISSN: 1946-6234